companydata.dkcompanydata.dk

Rinascibella Group ApS: Financial statements 2020

CVR: 29316082

Source: annual report 2020, Danish Business Authority

01/01/202031/12/2020

Rinascibella Group ApS (CVR 29316082) has filed annual accounts for 2020. In 2020, the company reported revenue of DKK 152,100 and a net result of DKK -14,022 compared with DKK 89,692 the year before. That is a decrease of 34.4% compared with the year before. The profit margin was -9.2%. Equity in the 2020 report amounted to DKK 312,510. The solvency ratio was 15.7%.

Revenue
DKK 152,100
Gross Profit
DKK 39,113
Profit/Loss
DKK -14,022
Equity
DKK 312,510
Total Assets
DKK 1,990,686

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2020152 t.39 t.-14 t.313 t.-
2019232 t.141 t.90 t.327 t.0
2018312 t.107 t.55 t.237 t.-
2017212 t.116 t.57 t.182 t.-
2016203 t.123 t.48 t.126 t.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is Rinascibella Group ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2020

Rinascibella Group ApS: The 2019 annual report is outAug 12, 2020

Rinascibella Group ApS has published its annual report for 2019. Revenue came to DKK 231,746, and the net result was DKK 89,692.

About Rinascibella Group ApS

Rinascibella Group ApS is a Danish company of the type Anpartsselskab based in Hinnerup, founded in 2006. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named MAKKY INVEST ApS. The management consists of Mehrdad Makky. The company is owned by MAKKY HOLDING ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -5,149 and a net result of DKK -6,061 compared with DKK 24,225 the year before. Equity in the 2025 report amounted to DKK 10,599.

Source: annual report 2025, Danish Business Authority